Meta-analysis of the melanoma miRNome identifies consensus signatures of progression and prognosis regulating metabolic plasticity and stress resistance

Meta-analysis of melanoma miRNome reveals 24 diagnostic and 23 prognostic miRNA signatures that regulate metabolic plasticity and stress resistance in melanoma progression.

• Why it matters: Accurate risk stratification in melanoma is hindered by molecular heterogeneity, making it difficult to identify patients at high recurrence risk and develop targeted therapies.
• What they did: A systems biology approach combined meta-analysis of six transcriptomic studies with network inference to identify key miRNA signatures and regulatory axes involved in melanoma progression.
• The result: The identified signatures, including miR-142-5p and miR-223-3p, serve as robust biomarkers for diagnosis and potential therapeutic targets, enabling more precise intervention strategies.